|
The pages of this web site article contain an in depth
discussion of a new and highly effective
neurotransmitter treatment of ADHD medical patients in clinics, without drugs or drug side effects. While on the surface this
approach may appear similar to treatment attempted by others
in the past, it is
differentiated from other approaches by the high
degree of effectiveness achieved and the unique
way the individual components are used. This
treatment approach
was developed by medical doctors caring for medical patients in their clinics while data basing treatment results. If you need assistance in finding a care giver using the NeuroResearch Clinics no-drug approach in treatment, we can help.
Attention Deficit
Drugs
The Attention Deficit Drugs
used in treatment of attention deficit (ADD
ADHD) are a member of one of two groups of drugs prescribed by doctors:
-
Amphetamines
-
Reuptake
Inhibitors
Amphetamines have multiple chemical properties,
they are reuptake inhibitors and they are
neurotoxins (cause permanent brain damage). Of
concern with prescription drugs is:
-
Amphetamines are neurotoxic.
(Adderall, Vyvanse)
-
Reuptake
inhibitors deplete neurotransmitters
(Concerta, Ritalin, Strattera, Focalin)
-
Drug side
effects (see drugs linked below)
Attention Deficit
Drugs
Reuptake inhibitors include
Concerta, Ritalin, Strattera and Focalin. These
drugs under normal conditions deplete neurotransmitters. The reuptake
inhibitor Attention Deficit Drugs share the problem that they quit working during
treatment at some
point in time. The reason for this is drugs that
work with neurotransmitters do not work if there
is not enough neurotransmitters to work with.
When the Attention Deficit Drugs quit
working it is because the neurotransmitter levels have just depleted by the drugs below what
levels needed to keep the drugs working. When one of these drugs quit working the standard approach in medicine is to:
-
increase the
drug dosing
-
add a second
drug
-
start a new drug
Each of the treatment options above only serve to deplete
neurotransmitter levels in the brain further making the cause of the problem worse.
These drugs make the cause of the problem worse,
"low neurotransmitter levels". With severe
depletion of neurotransmitters the risk of
suicide develops. All reuptake inhibitors used
to treat depression and attention deficit (ADD
ADHD) carry a suicide warning in their
prescribing information. For an in depth
discussion of how reuptake inhibitors deplete
neurotransmitters and induce suicide risk see
the links below.
Amphetamines
Examples of Attention Deficit Drugs
that are an amphetamine is Adderall and
Vyvanse. All amphetamines are
"neurotoxins"' causing permanent brain damage.
So what does brain damage from an amphetamine
look like? In the upper left column of
this web page is a link titled "The Diseases".
Click on it and it will take you to a list of
neurotransmitter diseases. These are the
diseases that can develop on a chronic basis
with amphetamine use. These diseases usually do
not develop while the amphetamine is being taken
instead they develop 3 to 5 years after
amphetamine ingestion stops.
The NeuroResearch
Approach
Unlike the Attention Deficit Drugs approach, the
approach of NeuroResearch Clinics uses nutrients
that build
neurotransmitters to levels needed for relief of
symptoms. The use of nutrients with
neurotransmitter testing is a powerful tool and
a unique option to Attention Deficit
Drugs.
The research findings of NeuroResearch Clinics
have not been ignored. The University of
Minnesota Medical School is writing a series of
papers on the neurotransmitter testing research of NeuroResearch Clinics. The first of a series of papers by University of Minnesota Medical School based on the neurotransmitter testing research of NeuroResearch was published in "NeuroPsychiatric Disease and Treatment" May 1, 2009. Ingrid
Kohlstadt, MD of Johns Hopkins in her new
medical text book released February 7, 2009
included a chapter on depression written by
Marty L. Hinz, MD President Clinical
Research NeuroResearch Clinics outlining in
depth the proper use of amino acids and
neurotransmitter testing in treatment of
depression.
|
